Jeffrey Gundlach’s Blood Feud With Morningstar: The Inside Story – ValueWalk Premium

Jeffrey Gundlach’s Blood Feud With Morningstar: The Inside Story

Is the genius of DoubleLine founder Jeffrey Gundlach on display resulting from his recent disagreement of opinion with Morningstar? And what exactly is the special sauce behind DoubleLine’s rather dramatic out-performance relative to industry benchmarks?

As DoubleLine today announces total firm net inflows of $688.7 million in July, with the flagship DoubleLine Total Return Bond Fund (DBTLX) snatching as much as $390.4 million in new assets alone, the firm founded in the wake of an . . .


This content is exclusively for paying members.

If you are subscribed and having an account error please clear cache and cookies if that does not work email or click chat.

Saved Articles

The Life and Career of Charlie Munger

Charlie is more than just Warren Buffett’s friend and Berkshire Hathaway’s Vice Chairman – Buffett has actually credited him with redefining how he looks at investing. Now you can learn from Charlie firsthand via this incredible ebook and over a dozen other famous investor studies by signing up below:

  • Learn from the best and forever change your investing perspective
  • One incredible tidbit of knowledge after another in the page-turning masterpiece of a book
  • Discover the secrets to Charlie’s success and how to apply it to your investing
Never Miss A Story!
Subscribe to ValueWalk Newsletter. We respect your privacy.

Here’s a Tip: Read What Professional Investors Read

ValueWalk Premium is for investors looking to improve their investment process AND keep up-to-date on the latest industry trends.

It’s THE resource for value investing and hedge funds. 📈

And with a free three-day trial and $29.99 per month thereafter, it’s a value in its own right.

Sign up now. 👇